AVONEX

Land: Israel

Språk: engelska

Källa: Ministry of Health

Aktiva substanser:

INTERFERON BETA 1A 30 MCG/VIAL

Tillgänglig från:

MEDISON PHARMA LTD

ATC-kod:

L03AB07

Läkemedelsform:

POWDER FOR SOLUTION FOR INJECTION

Administreringssätt:

I.M

Tillverkad av:

BIOGEN IDEC LTD, UK

Terapeutisk grupp:

INTERFERON BETA-1A

Terapeutiska indikationer:

Avonex is indicated for the treatment of relapsing forms of multiple sclerosis to slow the accumulation of physical disability and to decrease the frequency of clinical exacerbations. Avonex is also indicated for the treatment of patients who have experienced a single demyelinating event with an active inflammatory process if it is severe enough to warrant treatment with intravenous corticosteroids if alternative diagnosis have been excluded, including the prescence of MRI abnormalities characteristic of MS and if they are determined to be at high risk of developing clinically definite multiple sclerosis. Safety and efficacy in patients with chronic progressive multiple sclerosis has not been evaluated.

Tillstånd datum:

2011-11-01